Clinical Trial Detail

NCT ID NCT01738139
Title Ipilimumab and Imatinib Mesylate in Advanced Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors M.D. Anderson Cancer Center
Indications

melanoma

gastrointestinal stromal tumor

Advanced Solid Tumor

Therapies

Imatinib + Ipilimumab

Age Groups: senior child adult

Additional content available in CKB BOOST